In Parliament

My Lords, the Medicines and Healthcare products Regulatory Agency is engaging with Takeda Pharmaceuticals to ensure that, where appropriate,

My noble friend raises an important point.

I am grateful to my noble friend, but am not familiar with the paper to which she refers.

I thank the noble Baroness for that question.

The noble Lord raises a good point, and I agree with it.

My noble friend raises a very important point about communication.

I am most grateful to the noble Lord for his lifelong service to the community and to this House. He raises a very good point.

My Lords, I share the noble Lord’s disappointment that the company has taken the decision to withdraw Mobocertinib from the market globally.

The noble Lord raises a good point, and I agree with it.

I thank the noble Baroness for that question.